U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332416) titled 'Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening' on Jan. 08.
Brief Summary: The oral glucose tolerance test (OGTT) is the standard of care in the postpartum period to screen patients with gestational diabetes mellitus (GDM) for persistent dysglycemia. However, most patients find it burdensome and dread having to do it. Adherence rates are low (18-61%), impeding initiation of follow-up care to improve diabetes-related outcomes in subsequent pregnancies and long-term.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Gestational Diabetes
Intervention:
OTHER: Continuous glucose monitor...